Kidney disease
Product name | NGALKidney Injury Biomarker for distal tubular damage |
Cat-Nr. | KIT 036 |
Range | 0.4-100 ng/ml |
Sensitivity | 0.4 ng/ml |
Incubation time | 3.5 hours |
Sample volume | 100 μl |
Sample type | Urine (Suggested initial dilution of 1:20) |
Sample preparation | Urine: Plasma: Storage: |
Species | Human |
Cross reaction | Cross reactivity for other protein / peptides has not been tested |
Tests | 96 |
Method | ELISA |
Intended use | Human Neutrophil Gelatinase-Associated Lipocalin (NGAL) is a low molecular weight 25kDa glycoprotein and a member of the lipocalin superfamily, a family of small extracellular proteins that are characterized by the ability to bind small hydrophobic molecules. NGAL can also bind to specific cell surface receptors. Intended use: The NGAL EIA provides a method for the quantitative determination of NGAL in human urine, plasma and cell culture supernatant. NGAL is rapidly upregulated and released in response to injury and has demonstrated value as an early biomarker for the detection of acute kidney injury (AKI) onset in various clinical settings including:
NGAL has also been investigated as a biomarker of renal injury in:
Serum NGAL has been investigated as a biomarker of AKI onset in the critical care population |
Product informations |